357 related articles for article (PubMed ID: 12773448)
1. Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.
Romualdi D; Guido M; Ciampelli M; Giuliani M; Leoni F; Perri C; Lanzone A
Hum Reprod; 2003 Jun; 18(6):1210-8. PubMed ID: 12773448
[TBL] [Abstract][Full Text] [Related]
2. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
[TBL] [Abstract][Full Text] [Related]
3. Endocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia.
Ciotta L; De Leo V ; Farina M; Pafumi C; La Marca A ; Cianci A
Gynecol Obstet Invest; 2001; 51(1):44-50. PubMed ID: 11150875
[TBL] [Abstract][Full Text] [Related]
4. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
[TBL] [Abstract][Full Text] [Related]
5. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
[TBL] [Abstract][Full Text] [Related]
6. Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.
Guido M; Romualdi D; Suriano R; Giuliani M; Costantini B; Apa R; Lanzone A
Hum Reprod; 2004 Mar; 19(3):534-9. PubMed ID: 14998947
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
9. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
10. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.
Stabile G; Borrielli I; Artenisio AC; Bruno LM; Benvenga S; Giunta L; La Marca A; Volpe A; Pizzo A
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):177-82. PubMed ID: 24814528
[TBL] [Abstract][Full Text] [Related]
11. Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome.
Fulghesu AM; Cucinelli F; Pavone V; Murgia F; Guido M; Caruso A; Mancuso S; Lanzone A
Hum Reprod; 1999 Mar; 14(3):611-7. PubMed ID: 10221684
[TBL] [Abstract][Full Text] [Related]
12. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
Li L; Chen X; He Z; Zhao X; Huang L; Yang D
J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
[TBL] [Abstract][Full Text] [Related]
13. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
[TBL] [Abstract][Full Text] [Related]
14. Treatment of polycystic ovarian syndrome with insulin resistance by insulin-sensitizer.
Hu L; Shen H; Wu QF; Tian L; Hu MH
Clin Exp Obstet Gynecol; 2014; 41(3):288-92. PubMed ID: 24992778
[TBL] [Abstract][Full Text] [Related]
15. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.
Eldar-Geva T; Spitz IM; Groome NP; Margalioth EJ; Homburg R
Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573
[TBL] [Abstract][Full Text] [Related]
16. Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.
Glintborg D; Hermann AP; Andersen M; Hagen C; Beck-Nielsen H; Veldhuis JD; Henriksen JE
Fertil Steril; 2006 Aug; 86(2):385-97. PubMed ID: 16782094
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
19. Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance.
Ciotta L; Calogero AE; Farina M; De Leo V; La Marca A; Cianci A
Hum Reprod; 2001 Oct; 16(10):2066-72. PubMed ID: 11574493
[TBL] [Abstract][Full Text] [Related]
20. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements.
Spritzer PM; Poy M; Wiltgen D; Mylius LS; Capp E
Hum Reprod; 2001 Jul; 16(7):1340-6. PubMed ID: 11425810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
